Back to Trial

Oracle Runs

Oracle findings and outcome history for Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) (NCT07055880).

Runs
3
Findings
3
Latest Run
Apr 6, 2026, 2:57 PM
All Oracle Findings

Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.

NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)

Will the results be positive?

Trial NCT07055880 is Phase 2, sponsor Sinovac, status Not Yet Recruiting, primary completion 2026-01-15. No results posted or public readouts found in searches. Future trial precludes positive/negative readout.

Found Apr 6, 2026, 2:57 PMReviewed Apr 6, 2026, 3:00 PM
ClinicalTrialsclinicaltrials.gov
Immunogenicity and Safety of Different Dosages of Rabies ...
Status: Not Yet Recruiting. Estimated Primary Completion Date: January 15, 2026. No results section or outcomes posted.
Web Searchtheglobeandmail.comOct 28, 2025, 12:00 AM
Sinovac Biotech's New Rabies Vaccine Trial
Sinovac Biotech is conducting a Phase II clinical trial titled 'Immunogenicity and Safety of Two Dosages of Rabies Vaccine (Serum-free Vero... No results mentioned.
NO_DECISIONDismissed90% confidencemanual-chat-review

Will the results be positive?

ClinicalTrials.gov still lists this study as not yet recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.

Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:32 PM
ClinicalTrialsclinicaltrials.govJul 9, 2025, 12:00 AM
Study Details | NCT07055880 | ClinicalTrials.gov
ClinicalTrials.gov lists not yet recruiting; primary completion 2026-01-15; hasResults=false on the latest posted update.
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)

Will the results be positive?

Public evidence does not show a trial-specific readout. The cited records describe NCT07055880 as a Phase 2 protocol and list it as not yet enrolling / not yet recruiting, with endpoints and design only and no posted efficacy or safety outcome interpretation.

Found Apr 1, 2026, 6:36 PMReviewed Apr 1, 2026, 6:36 PM
ClinicalTrialsctv.veeva.com
Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
Trial listing for NCT07055880 shows Phase 2, status 'Not yet enrolling,' and provides study design/endpoints only; no results or sponsor framing of outcomes are posted.
ClinicalTrialscdek.pharmacy.purdue.eduAug 1, 2025, 12:00 AM
Trial | NCT07055880
Registry mirror for NCT07055880 also shows status 'NOT_YET_RECRUITING' and summarizes the planned study/primary endpoint, without any public result readout.
Outcome History

Public history of accepted oracle reviews and recorded outcome changes for this trial.

No oracle outcome history is available for this trial yet.